405 results
8-K
EX-99.1
dqle36eir1lsyrdhc91p
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
0ps q0m4e2
3 Apr 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:06pm
8-K
EX-4.6
e7cfu be4x2
26 Feb 24
Other Events
5:08pm
8-K
EX-4.2
3eoar
26 Feb 24
Other Events
5:08pm
8-K
EX-4.7
7bq 8nnct5nq
26 Feb 24
Other Events
5:08pm
8-K
EX-4.9
ah4iaqlnp4 y6
26 Feb 24
Other Events
5:08pm
8-K
EX-4.8
l4zut8bi6ablnma4
26 Feb 24
Other Events
5:08pm
8-K
EX-4.3
j65tvpouh6d1ng k8
26 Feb 24
Other Events
5:08pm
8-K
EX-4.5
u195x4acmncn6nzv
26 Feb 24
Other Events
5:08pm
8-K
EX-4.4
pnbaia
26 Feb 24
Other Events
5:08pm
424B5
jpgucbczv8lrip
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.5
68mma8 dtwj
22 Feb 24
Registration of securities for employees
5:50pm